MedPath

Eugia US LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

115

FDA:115

Drug Approvals

HYDRALAZINE HYDROCHLORIDE

Approval Date
Mar 12, 2024
FDA

Voriconazole

Approval Date
Mar 5, 2024
FDA

TESTOSTERONE ENANTHATE

Approval Date
Mar 2, 2024
FDA

Isoproterenol Hydrochloride

Approval Date
Feb 27, 2024
FDA

Dexamethasone Sodium Phosphate

Approval Date
Feb 23, 2024
FDA

Tranexamic Acid

Approval Date
Feb 19, 2024
FDA

Dexamethasone Sodium Phosphate

Approval Date
Feb 17, 2024
FDA

DEXAMETHASONE SODIUM PHOSPHATE

Approval Date
Feb 16, 2024
FDA

Isosulfan Blue

Approval Date
Feb 15, 2024
FDA

FOSAPREPITANT DIMEGLUMINE

Approval Date
Feb 13, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy